EUVIMEDEUVIMED entdecken
Crossref

Observation Effectiveness of Dose-Dense Neoadjuvant Anthracycline Sequential Weekly Paclitaxel for Triple-Negative Breast Cancer Patients

Xing Wang, Jiwei Wang, Yingjian He, Jinfeng Li, Tianfeng Wang, Tao Ouyang, Zhaoqing Fan

Clinical Breast Cancer · 2023-06 · 23 (4) · 423-430

DOI: 10.1016/j.clbc.2023.02.009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Breast Cancer, 2023-06. Verfasst von Xing Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Breast Center, Peking University Cancer Hospital & Insti…. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Breast Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsBreast NeoplasmsHumansFemalePaclitaxelAnthracyclinesNeoadjuvant TherapyAntineoplastic Combined Chemotherapy ProtocolsCyclophosphamideEpirubicin

Stichwörter der Autor:innen

Dose-dense chemotherapyNeoadjuvant chemotherapyPathological complete responsePrognosisTriple-negative breast cancer

Substanzen

PaclitaxelAnthracyclinesCyclophosphamideEpirubicin

Autor:innen und Institutionen

  • Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Breast Center, Peking University Cancer Hospital & Institute, Beijing, China.
  • Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Breast Center, Peking University Cancer Hospital & Institute, Beijing, China. Electronic address: breastcenter666@163.com.
  • Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Breast Center, Peking University Cancer Hospital & Institute, Beijing, China. Electronic address: zhqfan@sina.com.

Zitieren

APA

Wang, X., Wang, J., He, Y., Li, J., Wang, T., Ouyang, T., & Fan, Z. (2023). Observation Effectiveness of Dose-Dense Neoadjuvant Anthracycline Sequential Weekly Paclitaxel for Triple-Negative Breast Cancer Patients. Clinical Breast Cancer, 23(4), 423-430. https://doi.org/10.1016/j.clbc.2023.02.009

Vancouver

Wang X, Wang J, He Y, Li J, Wang T, Ouyang T, et al. Observation Effectiveness of Dose-Dense Neoadjuvant Anthracycline Sequential Weekly Paclitaxel for Triple-Negative Breast Cancer Patients. Clinical Breast Cancer. 2023;23(4):423-430. doi:10.1016/j.clbc.2023.02.009

BibTeX
@article{Wang2023,
  author = {Wang, Xing and Wang, Jiwei and He, Yingjian and Li, Jinfeng and Wang, Tianfeng and Ouyang, Tao and Fan, Zhaoqing},
  title = {Observation Effectiveness of Dose-Dense Neoadjuvant Anthracycline Sequential Weekly Paclitaxel for Triple-Negative Breast Cancer Patients},
  journal = {Clinical Breast Cancer},
  year = {2023},
  volume = {23},
  number = {4},
  pages = {423--430},
  doi = {10.1016/j.clbc.2023.02.009}
}
Kostenlos starten →